[Pharmacological aspects of fibrinolysis].
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000933:Antifibrinolytic Agents / Q000627:therapeutic use*; D001161:Arteriosclerosis / Q000188:drug therapy; D001779:Blood Coagulation Factors; D001780:Blood Coagulation Tests; D005342:Fibrinolysis / Q000187:drug effects*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy
D000893:Anti-Inflammatory Agents; D000933:Antifibrinolytic Agents; D001779:Blood Coagulation Factors; D005343:Fibrinolytic Agents
Aspetti farmacologici della fibrinolisi.